PubMed

Whole body PET/CT for initial staging of choroidal melanoma.

Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC.

Br J Ophthalmol. 2005 Oct;89(10):1270-4.PMID: 16170114 [PubMed - indexed for MEDLINE]Related articlesFree article

Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.

Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT.

Am J Ophthalmol. 2005 Aug;140(2):193-9.PMID: 15992753 [PubMed - indexed for MEDLINE]Related articles

Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.

Kurli M, Chin K, Finger PT.

Br J Ophthalmol. 2008 Apr;92(4):479-82.PMID: 18369064 [PubMed - indexed for MEDLINE]Related articles

Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

Yoon KT, Kim JK, Kim do Y, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.

Oncology. 2007;72 Suppl 1:104-10. Epub 2007 Dec 13.PMID: 18087190 [PubMed - indexed for MEDLINE]Related articles

Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.

Chin K, Finger PT, Kurli M, Tena LB, Reddy S.

Optometry. 2007 Aug;78(8):396-401.PMID: 17662928 [PubMed - indexed for MEDLINE]Related articles

High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

Strobel K, Dummer R, Husarik DB, Pérez Lago M, Hany TF, Steinert HC.

Radiology. 2007 Aug;244(2):566-74.PMID: 17641374 [PubMed - indexed for MEDLINE]Related articlesFree article

Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.

Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, Stützer H, Lackner K, Schicha H.

Nucl Med Commun. 1999 Mar;20(3):255-61.PMID: 10093075 [PubMed - indexed for MEDLINE]Related articles

PET/CT imaging: detection of choroidal melanoma.

Reddy S, Kurli M, Tena LB, Finger PT.

Br J Ophthalmol. 2005 Oct;89(10):1265-9.PMID: 16170113 [PubMed - indexed for MEDLINE]Related articlesFree article

Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.

Krug B, Dietlein M, Groth W, Stützer H, Psaras T, Gossmann A, Scheidhauer K, Schicha H, Lackner K.

Acta Radiol. 2000 Sep;41(5):446-52.PMID: 11016764 [PubMed - indexed for MEDLINE]Related articles

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.PMID: 18330088 [PubMed - indexed for MEDLINE]Related articles

Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.

Ho CL, Chen S, Yeung DW, Cheng TK.

J Nucl Med. 2007 Jun;48(6):902-9. Epub 2007 May 15.PMID: 17504862 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.

Gulec SA, Faries MB, Lee CC, Kirgan D, Glass C, Morton DL, Essner R.

Clin Nucl Med. 2003 Dec;28(12):961-5.PMID: 14663316 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of positron emission tomography for the detection of melanoma metastases.

Holder WD Jr, White RL Jr, Zuger JH, Easton EJ Jr, Greene FL.

Ann Surg. 1998 May;227(5):764-9; discussion 769-71.PMID: 9605668 [PubMed - indexed for MEDLINE]Related articlesFree article

Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.

Squillaci E, Manenti G, Mancino S, Cicciò C, Calabria F, Danieli R, Schillaci O, Simonetti G.

Abdom Imaging. 2008 Nov-Dec;33(6):676-88.PMID: 18373114 [PubMed - indexed for MEDLINE]Related articles

Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.

Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ 3rd, Hutchins G, Love C, Wenck S, Daggy J.

Cancer. 2005 Aug 1;104(3):570-9.PMID: 15977211 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.

J Clin Oncol. 2009 Oct 1;27(28):4774-80. Epub 2009 Aug 31.PMID: 19720925 [PubMed - indexed for MEDLINE]Related articles

3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?

Cobben DC, Jager PL, Elsinga PH, Maas B, Suurmeijer AJ, Hoekstra HJ.

J Nucl Med. 2003 Dec;44(12):1927-32.PMID: 14660718 [PubMed - indexed for MEDLINE]Related articlesFree article

Detection of metastatic disease in patients with uveal melanoma using positron emission tomography.

Francken AB, Fulham MJ, Millward MJ, Thompson JF.

Eur J Surg Oncol. 2006 Sep;32(7):780-4. Epub 2006 Jun 9.PMID: 16765562 [PubMed - indexed for MEDLINE]Related articles

Role of FDG-PET in the assessment of survival prognosis in melanoma.

Pleiss C, Risse JH, Biersack HJ, Bender H.

Cancer Biother Radiopharm. 2007 Dec;22(6):740-7.PMID: 18158764 [PubMed - indexed for MEDLINE]Related articles

[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.

Jadvar H, Henderson RW, Conti PS.

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8.PMID: 17414758 [PubMed - indexed for MEDLINE]Related articles